Analyst ratings and price targets can significantly influence a stock's performance. In this case, JMP Securities has reiterated a Market Outperform rating on AMERISAFE, indicating that they expect the stock to outperform the market. They have also maintained a $65 price target, suggesting they believe the stock is currently undervalued. This could lead to increased investor interest and a potential rise in the stock's price.